United States
Germany
Japan
United Kingdom
China
CNY 1,999.00
CNY 2,700.00
现货
Anti-LTA4H (Leukotriene A4 hydrolase) mouse monoclonal antibody, clone OTI1E9 (formerly 1E9)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
热销推荐
Antibodies
Anti-USP13 mouse monoclonal antibody, clone OTI4G11 (formerly 4G11)
| Applications | IHC, IP, WB |
| Reactivities | Human, Monkey, Dog, Mouse, Rat |
Anti-TUBA8 mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 1,999.00
CNY 2,700.00
现货
Anti-LTA4H (Leukotriene A4 hydrolase) mouse monoclonal antibody, clone OTI8F4 (formerly 8F4)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Mouse |
Anti-SSB mouse monoclonal antibody, clone OTI9D6 (formerly 9D6)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog, Monkey |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI6E5 (formerly 6E5)
| Applications | IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
GAD1 (GAD67) mouse monoclonal antibody, clone OTI3H2 (formerly 3H2)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
Anti-FERMT2 mouse monoclonal antibody, clone OTI14A11 (formerly 14A11)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CNY 3,999.00
2周
Anti-SSB mouse monoclonal antibody, clone OTI3H9 (formerly 3H9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog |
Anti-LEMD3 (MAN1) mouse monoclonal antibody, clone OTI6C10 (formerly 6C10)
| Applications | IP, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
clear Category
- Antibodies
优化搜索结果
Target Symbol
Knockout (KO) Validation
Isotypes
Clonalities
Assay Types
Families
Pathways
- Pathways in cancer (39)
- Progesterone-mediated oocyte maturation (39)
- Bladder cancer (36)
- ErbB signaling pathway (36)
- MAPK signaling pathway (36)
- Pancreatic cancer (36)
- Acute myeloid leukemia (33)
- Chemokine signaling pathway (33)
- Chronic myeloid leukemia (33)
- Colorectal cancer (33)
- Endometrial cancer (33)
- Focal adhesion (33)
- Glioma (33)
- Insulin signaling pathway (33)
- Long-term depression (33)
- Long-term potentiation (33)
- Melanoma (33)
- Natural killer cell mediated cytotoxicity (33)
- Neurotrophin signaling pathway (33)
- Non-small cell lung cancer (33)
- Prostate cancer (33)
- Regulation of actin cytoskeleton (33)
- Renal cell carcinoma (33)
- Thyroid cancer (33)
- Vascular smooth muscle contraction (33)
- mTOR signaling pathway (33)
- Oocyte meiosis (30)
- Fc epsilon RI signaling pathway (27)
- Gap junction (27)
- GnRH signaling pathway (27)
- Toll-like receptor signaling pathway (27)
- Adherens junction (24)
- Alzheimer's disease (24)
- Axon guidance (24)
- B cell receptor signaling pathway (24)
- Dorso-ventral axis formation (24)
- Fc gamma R-mediated phagocytosis (24)
- Melanogenesis (24)
- NOD-like receptor signaling pathway (24)
- Prion diseases (24)
- T cell receptor signaling pathway (24)
- TGF-beta signaling pathway (24)
- Type II diabetes mellitus (24)
- VEGF signaling pathway (24)
- Cell cycle (21)
- Systemic lupus erythematosus (18)
- p53 signaling pathway (15)
- Complement and coagulation cascades (12)
- Metabolic pathways (9)
- Arachidonic acid metabolism (6)
- DNA replication (6)
- Homologous recombination (6)
- Mismatch repair (6)
- Nucleotide excision repair (6)
- Alanine (3)
- Butanoate metabolism (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Pathogenic Escherichia coli infection (3)
- Taurine and hypotaurine metabolism (3)
- Type I diabetes mellitus (3)
- aspartate and glutamate metabolism (3)
- beta-Alanine metabolism (3)
